NCT04872920View on ClinicalTrials.gov

Observational Registry on Patients With Endogenous CS to Document Safety and Effectiveness of Ketoconazole.

UnknownOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

December 20, 2018

Primary Completion Date

March 1, 2023

Study Completion Date

March 1, 2024

Conditions
Cushing Syndrome
Trial Locations (6)

Unknown

RECRUITING

University Hospital Zagreb, Zagreb

RECRUITING

Hôpital Universitaire Grenoble, Grenoble

RECRUITING

Hôpital Bicêtre APHP, Le Kremlin-Bicêtre

RECRUITING

Hôpital de la Conception, Marseille

RECRUITING

Institut de Recerca de la Santa Creu i Sant Pau, Barcelona

RECRUITING

Sahlgrenska University Hospital, Gothenburg

Sponsors

Lead Sponsor

HRA Pharma
All Listed Sponsors
lead

HRA Pharma

INDUSTRY

NCT04872920 - Observational Registry on Patients With Endogenous CS to Document Safety and Effectiveness of Ketoconazole. | Biotech Hunter | Biotech Hunter